Next Generation Oral Therapeutics Targeting the Immune Response

RAPT Therapeutics is focused on the development of oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing our proprietary discovery platform, we develop highly selective small molecules that are designed to modulate the critical immune responses underlying these diseases.

RAPT Pipeline
Click To View Full Image In New Window


Read more: